U
IMMU

UBS’s Immunomedics Inc IMMU Stock Holding History

UBS’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$252K Buy
67,700
+39,900
+144% +$135K ﹤0.01% 4955
2014
Q2 		$101K Sell
27,800
-65,600
-70% -$241K ﹤0.01% 5931
2014
Q1 		$393K Sell
93,400
-168,100
-64% -$834K ﹤0.01% 4504
2013
Q4 		$1.2M Buy
261,500
+20,600
+9% +$91.7K ﹤0.01% 3332
2013
Q3 		$1.49M Buy
240,900
+33,100
+16% +$191K ﹤0.01% 2901
2013
Q2 		$1.13M Buy
+207,800
New +$683K ﹤0.01% 3196

Other funds holding IMMU

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

UBS's IMMU Position: Q3 2014 in Review

UBS reduced its Immunomedics Inc (IMMU) stake by 19% in Q3 2014, selling an estimated $16.4K and leaving 20,450 shares worth $76K. The position accounts for ﹤0.01% of the portfolio, ranked #6327.

UBS first reported a position in IMMU in Q2 2013 and has held it in 6 quarters since. The position peaked at $105K in Q4 2013. 81 funds tracked by Wall St. Rank hold IMMU as of Q3 2014.

  • UBS held 20,450 shares of Immunomedics Inc worth $76K as of Q3 2014.
  • UBS sold 4,865 Immunomedics Inc shares in Q3 2014, an estimated $16.4K.
  • Immunomedics Inc made up ﹤0.01% of UBS's portfolio in Q3 2014, its #6327 holding.
  • UBS first reported a position in Immunomedics Inc in Q2 2013 and has held it in 6 quarters since.
  • UBS's Immunomedics Inc position peaked at $105K in Q4 2013.
  • 81 funds tracked by Wall St. Rank held Immunomedics Inc as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.